RESEARCH PROJECTS OF DELOGU'S LAB:
HELICAL - H2020-MSCA-ITN
HEalth data Lnkage for CliniAL benefict (HELICAL) provides training in analysis of large datasets to elucidate the complex biology of chronic diseases. HELICAL exploits recent advances in data science to link research datasets with longitudinal healthcare records, based on the robust ethical foundation required for linkage studies using near-patient data, to address key experimental questions. The training provided addresses a key skills gap in the European workforce and should make the ESR eminently employable in academic, industrial and clinical sectors.
WHISKIES - WOUND HEALING IN SPACE: KEY CHALLENGES TOWARDS INTELLIGENT AND EABLING SENSING PLATFORMS
WHISKIES stems from the European Space Agency Topical Team Network “Tissue Healing in Space: Techniques for promoting and monitoring tissue repair and regeneration” (https://www.thm-esatt.net). Human Space Exploration has always been a powerful driving force to develop ground-breaking solutions, foundational technology, and new approaches. It is also worthy to notice that Space could be considered a unique remote environment. Solutions found for Space applications could, then, help managing problems existing on-ground for rural areas. We believe that, by taking advantage of the Space environment, WHISKIES can contribute to these efforts for a better, innovative, efficient and patient-centered health care ecosystem.
IMM-GNRs, CALL MSCA IF Horizon 2020
As Overall Goal IMM-GNRs intends to overcome the aforementioned limits of conventional nano-immunotoxicology approaches. IMM-GNRs will provide a comprehensive and quantitative picture of the GNRs immune activity in relation to their structural properties (shape, edge structures, width, size, molecular weight).
CARBO-IMmap, CALL RISE under Horizon 2020
The CARBO-IMmap project major aim is to advance the field of carbon nanomaterial development and their exploitation biomedical applications. The long-range goal of Carbo-IMmap is to develop a functional pipeline for the immune-characterization of carbon nanomaterials, for the qualitative and quantitative assessment in vitro and ex vivo of the human immune compatibility and immune activity of newly developed carbon materials.
The program will enable long-term, transformative research collaborations that will contribute to the integration and collaboration of research groups of 4 European Countries (Germany, Italy, France and Spain) and 3 key non-EU Countries: USA, China and Qatar.
Multifunctional nanotool for advanced cancer diagnostics, PRIN 2016 under the Italian MIUR
The overriding goal of this research program is to develope innovative materials and explore novel strategies for the detection of tumor markers. The project will lead to the development of nanotools that, by joining the advantageous features of nanometer-scale carbon-based materials and biological recognition elements, will allow the detection of tumor markers with high sensitivity and specificity.
G-IMMUNOMICS, call FlagERA 2015 under Horizon 2020
Graphene is the most promising, versatile, and sustainable key enabling nanotechnology which may bring solutions in the near future to many areas spanning materials science and medicine.
The overall objective of G-IMMUNOMICS is to complement Flagship research on graphene safety with immunogenomic and proteomic data, not covered by the Core Project. G-IMMUNOMICS will provide new insights on the immune impact of several types of graphene to lay the basis for a safe use of graphene and the graphene technology future transfer in medicine. The specific objectives are:
1- Produce highly stable and dispersible pristine and functionalized graphene family materials (GFMs) with different lateral size and appropriate functionalizations
2- Characterize by high throughput functional immunogenomics and proteomics approaches and genotoxic assays the immune cell response induced by GFMs on different cell lines and primary cell.
3- Evaluate the immune cell response induced by GFMs on four different species: human, mouse, pig and worm.
G-NANOULTRA: Graphene as a new nanocontrast agent for cancer ultrasonography diagnosis and therapy
Ultrasonography (US) is used in every day clinical practice. Current US contrast agents (USCAs) are exclusively diagnostic tools. We showed great potential of carbon nanomaterials as USCAs (Delogu LG et al PNAS 2012). The project G-NANOULTRA is based on a solid international network of collaborations and the expertise in nanobiotechnology of the PI. We aim at develop new carbon USCAs based on graphene with multiple functions such as: cancer diagnosis, immunotherapy and fast drug delivery.